Related Experiment Video
Updated: May 7, 2026

10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
17.1K
A general computational design strategy for stabilizing viral class I fusion proteins
Karen J Gonzalez1, Jiachen Huang2,3, Miria F Criado3,4
1Institute of Bioinformatics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, 30602, USA.
Nature Communications
|February 13, 2024
Summary
This study introduces a computational method to stabilize viral prefusion proteins, enhancing vaccine development. The approach successfully redesigned fusion proteins from multiple viruses, showing promise for future immunogens.
Area of Science:
- Structural biology
- Virology
- Immunology
Background:
- Class I fusion proteins are critical for viral entry into host cells.
- Antibodies targeting the prefusion conformation of these proteins are highly effective for vaccines.
- Stabilizing the prefusion state is a key strategy for developing potent viral vaccines.
Purpose of the Study:
- To develop a computational protocol for stabilizing viral class I fusion proteins in their prefusion conformation.
- To destabilize the postfusion conformation of these proteins.
- To accelerate vaccine design for viruses utilizing class I fusion proteins.
Main Methods:
- A computational design protocol was established to stabilize prefusion conformations.
- The protocol was applied to fusion proteins from Respiratory Syncytial Virus (RSV), human Metapneumovirus (hMPV), and SARS-CoV-2.
- Structural analysis and immunological studies were performed on designed proteins.
Main Results:
- The computational protocol successfully stabilized the prefusion state of RSV, hMPV, and SARS-CoV-2 fusion proteins.
- Solved structures confirmed the atomic accuracy of the designed proteins.
- The redesigned RSV F protein elicited a humoral response comparable to an approved vaccine in a mouse model.
Conclusions:
- The developed computational protocol is effective in stabilizing viral prefusion fusion proteins.
- This approach significantly reduces the time and resources required for immunogen optimization.
- The protocol has broad applicability for developing vaccines against viruses employing class I fusion proteins.

